Association between severity of knee osteoarthritis and serum and synovial fluid interleukin 17 concentrations

Abstract

Objective

To determine interleukin (IL)-17 concentrations in serum and synovial fluid from patients with knee osteoarthritis, and evaluate their correlation with disease severity.

Methods

Serum and synovial fluid were collected from patients with primary knee osteoarthritis; age- and sex-matched healthy control subjects provided serum samples. This study was conducted retrospectively. IL-17 was quantified by enzyme-linked immunosorbent assay. Osteoarthritis severity and grade were assessed using the Lequesne index and Kellgren and Lawrence (KL) grading system, respectively.

Results

Serum IL-17 concentrations were significantly higher in patients (n = 98) than in controls (n = 50). In the patient group, the synovial fluid IL-17 concentration increased significantly with KL grade and was significantly positively correlated with Lequesne index (r = 0.6232).

Conclusions

The synovial fluid IL-17 concentration could represent a useful biochemical marker to reflect knee osteoarthritis severity and progression.

Keywords

Interleukin 17 knee osteoarthritis plasma synovial fluid

Introduction

Osteoarthritis is a chronic, degenerative joint disease characterized by the progressive destruction of articular cartilage, joint-space narrowing, subchondral bone remodelling, joint marginal osteophyte formation and synovitis.¹ Osteoarthritis causes joint pain, stiffness, swelling and reduced range-of-motion in middle-aged and older people, and has a serious impact on health-related quality-of-life.² Osteoarthritis can be diagnosed by the presence of joint irregularities and deformities on X-radiographic images, with the grade of joint degeneration being reflective of disease severity.³ Noninvasive biochemical analyses have been developed to evaluate disease progress and severity, and provide a nonradiographical alternative for the early detection of osteoarthritis.^4–6 Although the aetiology and pathophysiology of osteoarthritis are both poorly understood, it is believed that secreted inflammatory molecules (such as proinflammatory cytokines) are among the critical mediators of the disturbed processes implicated in osteoarthritis pathophysiology.⁷ Proinflammatory cytokines have been reported to contribute to osteoarthritis pathogenesis by increasing cartilage degradation and inducing hyperalgesia via a number of direct and indirect actions.⁸

The proinflammatory cytokine interleukin (IL)-17 is implicated in both the induction of local inflammation and the joint destruction that characterize the synovial tissue of rheumatoid arthritis.^9,10 IL-17 is present at increased concentrations in serum, synovial fluid and synovium samples from patients with rheumatoid arthritis,¹¹ and has been shown to induce and perpetuate chronic inflammation, cartilage damage and bone erosion.¹² Osteoarthritis shares several characteristics with rheumatoid arthritis, including joint destruction and synovitis.¹³ In addition, IL-17 has been shown to be present in synovial fluid from patients with osteoarthritis,¹⁴ but the relationship between serum and synovial fluid IL-17 concentrations and severity of primary knee osteoarthritis remains to be clarified.

The aim of the present retrospective study was to investigate IL-17 concentrations in serum and synovial fluid samples from patients with primary knee osteoarthritis, and assess their possible relationship with disease severity.

Patients and methods

Study population

The retrospective study included serum and synovial fluid samples from Han Chinese patients with primary knee osteoarthritis, who attended the Department of Orthopaedic Surgery, Zhongnan Hospital, Wuhan, China for diagnosis and treatment, between 1 January 2008 and 31 December 2012. Diagnosis of osteoarthritis was performed according to criteria of the American College of Rheumatology.¹⁴ Exclusion criteria were: (i) symptoms suggestive of any other chronic inflammatory disease; (ii) diabetes; (iii) history of corticosteroid treatment; (iv) any other form of arthritis; (v) cancer; (vi) family history of osteoarthritis.

Serum samples from age- and sex-matched healthy subjects were used as controls; these samples had been provided by members of the local population and medical staff of Zhongnan Hospital who were attending the hospital for routine medical checks. The control subjects were ethnically matched and had no symptoms suggestive of gout, rheumatoid arthritis, trauma, diabetes or any orthopaedic disease.

The study protocol was approved by the Ethics Committee of Wuhan University Zhongnan Hospital, Wuhan, China, and all participants provided written informed consent.

IL-17 quantification

Whole blood (5 ml) was collected in serum separator tubes, allowed to clot for 30 min and centrifuged for 15 min at 1000 g at room temperature. The resulting serum was removed and stored at −80℃ until use. Synovial fluid (1 ml) was aspirated from the affected knee of patients by needle aspiration with the use of a sterile technique. Each SF sample was placed in a sterile polypropylene tube, centrifuged at 1000 g for 10 min at room temperature to remove cells and joint debris, then frozen at −80℃ until analysis. IL-17 was quantified by enzyme-linked immunosorbent assay (Bender Medsystems, Vienna, Austria), according to the manufacturer’s protocol. Each sample was tested in triplicate.

Grading and assessment of osteoarthritis

Osteoarthritis was graded based on weight-bearing anteroposterior X-radiographs of the affected knee, according to the Kellgren and Lawrence (KL) grading system3 as follows: grade 0, no radiological changes; grade 1, doubtful narrowing of joint space and possible osteophytic lipping; grade 2, definite osteophytes and possible narrowing of joint space; grade 3, moderate multiple osteophytes, definite narrowing of joint space, some sclerosis and possible deformity of bone contours; grade 4, large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone contours.¹⁴ For the purposes of this study, patients were required to have KL grade ≥2 in at least one knee. Disease severity was assessed using the standardized Lequesne algofunctional index, which evaluates pain/discomfort, maximum distance walked and activities of daily living.¹⁵

Statistical analyses

Continuous variables were presented as mean ± SD, and compared using two-tailed Student’s t-test or one-way analysis of variance. Relationships between variables were examined using nonparametric Spearman correlation coefficients. Statistical analyses were performed with SPSS® version 15.0 (SPSS Inc., Chicago, USA) for Windows®. P-values < 0.05 were considered statistically significant.

Results

The study recruited 100 patients with primary knee osteoarthritis (21 male/79 female; mean age 61.98 ± 7.18 years; age range 40–75 years) and 50 age- and sex-matched healthy control subjects (10 male/40 female; mean age 58.58 ± 7.61 years; age range 40–75 years). Two female patients with KL grade 4 were excluded from the study due to inability to collect a sample of synovial fluid. The baseline clinical characteristics of the study population are displayed in Table 1. There were no statistically significant differences in age, sex or body mass index between patients and controls.

Table 1.

Baseline demographic and clinical characteristics of Han Chinese patients with primary knee osteoarthritis and matched healthy control subjects included in a study investigating the association between IL-17 and severity of knee osteoarthritis.

Characteristic	Control group n = 50	Patient group
Characteristic	Control group n = 50	Total n = 98	KL grade 2 n = 34	KL grade 3 n = 35	KL grade 4 n = 29
Age, years	58.58 ± 7.61	61.98 ± 7.18	59.16 ± 7.45	62.57 ± 6.22	64.23 ± 7.15
Sex, male/female	10/40	21/77	6/28	8/27	7/22
BMI, kg/m²	21.07 ± 1.86	22.17 ± 1.67	22.20 ± 1.73	21.87 ± 1.51	22.49 ± 1.78

Data presented as mean ± SD or n.

KL, Kellgren and Lawrence grading system;³ BMI, body mass index.

No statistically significant between-group differences (P ≥ 0.05; Student’s t-test or one-way analysis of variance).

Concentrations of IL-17 in serum and synovial fluid are shown in Table 2. Serum IL-17 concentrations were significantly higher in the total patient group than in controls (P < 0.05). When patients were stratified according to KL grade, IL-17 serum concentrations were significantly higher in patients with grade 4 osteoarthritis than in controls (P < 0.05). There were no significant differences between patients with grade 2 or grade 3 osteoarthritis and controls, however.

Table 2.

Inkerleukin (IL)-17 concentrations in serum samples from healthy control subjects, and serum and synovial fluid samples from Han Chinese patients with primary knee osteoarthritis.

IL-17, pg/ml	Control group n = 50	Patient group
IL-17, pg/ml	Control group n = 50	Total n = 98	KL grade 2 n = 34	KL grade 3 n = 35	KL grade 4 n = 29
Serum	4.173 ± 0.640	5.292 ± 1.470^a	4.405 ± 0.750	4.474 ± 0.816	6.161 ± 1.120^abc
Synovial fluid	NT	6.625 ± 1.818	5.565 ± 1.660	6.726 ± 1.515^d	8.701 ± 2.154^de

Data presented as mean ± SD.

KL, Kellgren and Lawrence grading system;³ NT, not tested.

Serum IL-17 concentrations: ^aP < 0.05 vs control group, ^bP < 0.05 vs KL grade 2, ^cP < 0.05 vs KL grade 3; Synovial fluid IL-17 concentrations: ^dP < 0.05 vs KL grade 2, ^eP < 0.05 vs KL grade 3; Student’s t-test or one-way analysis of variance.

Synovial fluid IL-17 concentrations were significantly higher in patients with grade 3 or 4 osteoarthritis than in those with grade 2, and significantly higher in patients with grade 4 than those with grade 3 disease (P < 0.05 for each comparison; Table 2).

Synovial fluid IL-17 concentrations were significantly positively correlated with Lequesne index (r = 0.6232, P < 0.05; Figure 1). There was no correlation between serum IL-17 concentrations and Lequesne index, however.

Figure 1.

Correlation between interleukin (IL)-17 concentration in synovial fluid and Lequesne index of disease severity¹⁵ in Han Chinese patients with primary knee osteoarthritis (n = 98).

Discussion

The current study demonstrated that IL-17 was detectable in serum and knee synovial fluid samples from patients with knee osteoarthritis, and found a positive association between the severity of knee osteoarthritis (KL grade) and the IL-17 concentration. In addition, synovial fluid IL-17 concentrations were positively correlated with Lequesne index,¹⁵ suggesting that IL-17 may play an important role in the pathogenesis of osteoarthritis.

The present data are in accordance with others, who found that increased synovial fluid IL-17 concentrations were correlated with arthritis disease activity and matrix metalloproteinase expression in synovial fibroblasts, suggesting a role for this cytokine in cartilage destruction.^16,17 In addition, IL-17 has been shown to induce the release of chemokines (such as IL-1β and tumour necrosis factor [TNF]-α) by chondrocytes and synovial fibroblasts, contributing to cartilage breakdown and synovial infiltration in osteoarthritis.¹³ Others demonstrated that IL-17 inhibited proteoglycan synthesis in rat cartilage, and increased nitrogen monoxide production.¹⁸ Although the aetiology and pathogenesis of osteoarthritis are poorly understood, it is possible that IL-17 may be among the critical mediators of the disturbed processes implicated in osteoarthritis pathophysiology.

Activated memory CD4⁺ T-cells are the primary secretors of IL-17, which then binds to specific receptors that are expressed by virtually all cells and tissues.⁹ Increasing evidence suggests a pathogenic role for IL-17 in the structural damage of rheumatoid arthritis,¹⁹ promoting cartilage and bone destruction by acting as potent inductor of matrix metalloproteinase and receptor activator of nuclear factor κB ligand expression in rheumatoid synoviocytes and osteoblasts.^10,20,21 In addition, data suggest that IL-17 may be important in recruiting monocytes into the joints of patients with rheumatoid arthritis, and in promoting the secretion of inflammatory cytokines and chemokines from rheumatoid arthritis synovial tissue.¹⁰ There is evidence to suggest that IL-17 plays a key role in the synergistic or additive effects of TNF-α and IL-1 in rheumatoid arthritis.^22,23 The disease process of osteoarthritis begins with cartilage degradation, which triggers the inflammatory cascade, resulting in similar symptoms to rheumatoid arthritis. Although rheumatoid arthritis and osteoarthritis have different aetiologies, the diseases share several common characteristics including destruction of articular cartilage, joint space narrowing and synovitis.²⁴

The concentration of IL-17 in synovial fluid, but not serum, was found to correlate significantly with Lequesne index (an objective assessment of osteoarthritis severity) in the current study. The increased IL-17 concentrations in synovial fluid may be attributable to the increased local and systemic production of IL-17 by synovial cells and chondrocytes in local and extra-articular tissues. Inflamed synovial tissue and stimulated chondrocytes may stimulate increased IL-17 production, which could then contribute to the initiation or worsening of synovial inflammation, leading to a vicious cycle.²⁵

This is a small article and the study design may be simple. Nevertheless, in this article we have attempted to express the correlation between knee osteoarthritis severity and IL-17 concentration, and we acknowledge that further studies are necessary to validate these findings. Such studies might investigate, for example, random samples taken from patients from multiple centres, mRNA expression of IL-17 in synovial fluid mononuclear cells according to KL grade, relationship between inflammation and osteoarthritis, as well as studying the differences between osteoarthritis and rheumatoid arthritis. In addition, we acknowledge that ethical concerns meant that it was not possible to obtain synovial fluid from the knee joints of control participants, which may have led to a potential bias.

In conclusion, the present study findings demonstrate a positive correlation between disease severity (Lequesne index) and IL-17 concentrations in synovial fluid from the affected joint of patients with primary knee osteoarthritis. Synovial fluid IL-17 could represent a useful biochemical marker to reflect knee osteoarthritis severity and progression. In addition, blocking IL-17/IL-17 receptor signalling may be a novel therapeutic approach to the control of osteoarthritis symptoms and the prevention of joint destruction.

Footnotes

Declaration of conflicting interest

The authors declare that there are no conflicts of interest.

Funding

This research was supported by grants from the Natural Science Foundation of China (81201401 and 30973539) and the Fundamental Research Funds for the Central Universities (303274010).

References

Lories

Luyten

. The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 2011; 7: 43–49.

Egloff

Hügle

Valderrabano

. Biomechanics and pathomechanisms of osteoarthritis. Swiss Med Wkly 2012; 142: w13583–w13583.

Kellgren

Lawrence

. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494–502.

Han

Dai

Zhang

. Identification of osteoarthritis biomarkers by proteomic analysis of synovial fluid. J Int Med Res 2012; 40: 2243–2250.

Honsawek

Yuktanandana

Tanavalee

. Correlation between plasma and synovial fluid basic fibroblast growth factor with radiographic severity in primary knee osteoarthritis. Int Orthop 2012; 36: 981–985.

Ning

Ishijima

Kaneko

. Correlations between both the expression levels of inflammatory mediators and growth factor in medial perimeniscal synovial tissue and the severity of medial knee osteoarthritis. Int Orthop 2011; 35: 831–838.

Orita

Koshi

Mitsuka

. Associations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee. BMC Musculoskelet Disord 2011; 12: 144–144.

Zhu

Qian

. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin Sci (Lond) 2012; 122: 487–511.

Shahrara

Pickens

Dorfleutner

. IL-17 induces monocyte migration in rheumatoid arthritis. J Immunol 2009; 182: 3884–3891.

10.

Roşu

Mărgăritescu

Stepan

. IL-17 patterns in synovium, serum and synovial fluid from treatment-naïve, early rheumatoid arthritis patients. Rom J Morphol Embryol 2012; 53: 73–80.

11.

Peck

Mellins

. Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin Immunol 2009; 132: 295–304.

12.

Alaaeddine

Okais

Ballane

. Use of complementary and alternative therapy among patients with rheumatoid arthritis and osteoarthritis. J Clin Nurs 2012; 21: 3198–3204.

13.

Honorati

Bovara

Cattini

. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthr Cartil 2002; 10: 799–807.

14.

Morrell

Heinze

. Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores. Semin Arthritis Rheum 2005; 35: 197–201.

15.

Lequesne

Mery

Samson

. Indexes of severity for osteoarthritis of the hip and knee. Validation–value in comparison with other assessment tests. Scand J Rheumatol Suppl 1987; 65: 85–89.

16.

Agarwal

Misra

Aggarwal

. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 2008; 35: 515–519.

17.

Neogi

Zhang

. Epidemiology of osteoarthritis. Rheum Dis Clin North Am 2013; 39: 1–19.

18.

Pacquelet

Presle

Boileau

. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis. J Rheumatol 2002; 29: 2602–2610.

19.

Miossec

Kolls

. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012; 11: 763–776.

20.

Hwang

Kim

. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther 2004; 6: R120–R128.

21.

Granet

Maslinski

Miossec

. Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. Arthritis Res Ther 2004; 6: R190–R198.

22.

Van Bezooijen

Van Der Wee-Pals

Papapoulos

. Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Ann Rheum Dis 2002; 61: 870–876.

23.

Lubberts

Koenders

van den Berg

. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 2005; 7: 29–37.

24.

Haseeb

Haqqi

. Immunopathogenesis of osteoarthritis. Clin Immunol 2013; 146: 185–196.

25.

Merashly

Uthman

. Management of knee osteoarthritis: an evidence-based review of treatment options. J Med Liban 2012; 60: 237–242.